FDA Drug recall D-0925-2018
Admelog Solostar (insulin lispro injection), 100 units/ mL (U-100) injection, packaged in 3mL prefilled pens, 1 pen per box, Rx only, Physi…
- FDA Drug
- Class II
- ongoing
- Published 2018-07-18
On 2018-07-18 the FDA classified a Class II recall of Admelog Solostar (insulin lispro injection), 100 units/ mL (U-100) injection, packaged in 3mL prefilled pens, 1 pen per box, Rx only, Physi… by Sanofi Aventis U S, citing temperature Abuse: Product samples of Admelog may not have been shipped at proper temperature.
Read the official FDA Drug notice
| Agency | FDA Drug |
|---|---|
| Recall number | D-0925-2018 |
| Classification | Class II |
| Status | ongoing |
| Initiated | 2018-07-05 |
| Published | 2018-07-18 |
| Last updated | 2026-09-13 11:52 UTC |
| Company | Sanofi Aventis U S |
| Distribution | US |
Product
Admelog Solostar (insulin lispro injection), 100 units/ mL (U-100) injection, packaged in 3mL prefilled pens, 1 pen per box, Rx only, Physician Sample - Not For Sale, Sanofi-Aventis U.S. LLC, Bridgewater, NJ 08807, NDC 0024-5925-00
Reason
Temperature Abuse: Product samples of Admelog may not have been shipped at proper temperature.
Identifiers
| ndc | 0024-5924-10 |
|---|---|
| ndc | 0024-5925-01 |
| ndc | 0024-5925-05 |
| ndc | 0024-5925-00 |
| ndc | 0024-5926-05 |
| code_info | Lot #: 7F021B, Exp 6/30/20 |
Status history
No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:52 UTC. Current status: ongoing.
Source
Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0925-2018%22
RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.